AJ Wealth Strategies’s Catalyst Pharmaceutical CPRX Stock Holding History

AJ Wealth Strategies’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$205K	Hold	15,241	–	–	0.01%	282
2023 Q1	$253K	Hold	15,241	–	–	0.01%	249
2022 Q4	$283K	Sell	15,241 -730	-5%	-$11.2K	0.01%	242
2022 Q3	$205K	Hold	15,971	–	–	0.01%	277
2022 Q2	$112K	Hold	15,971	–	–	0.01%	291
2022 Q1	$132K	Hold	15,971	–	–	0.01%	305
2021 Q4	$108K	Sell	15,971 -2,299	-13%	-$15.1K	0.01%	294
2021 Q3	$97K	Hold	18,270	–	–	0.01%	288
2021 Q2	$105K	Hold	18,270	–	–	0.01%	268
2021 Q1	$84K	Hold	18,270	–	–	0.01%	258
2020 Q4	$61K	Hold	18,270	–	–	0.01%	239
2020 Q3	$54K	Hold	18,270	–	–	0.01%	220
2020 Q2	$84K	Hold	18,270	–	–	0.01%	198
2020 Q1	$70K	Hold	18,270	–	–	0.01%	172
2019 Q4	$69K	Sell	18,270 -1,230	-6%	-$5.75K	0.01%	120
2019 Q3	$104K	Hold	19,500	–	–	0.01%	113
2019 Q2	$75K	Hold	19,500	–	–	0.01%	102
2019 Q1	$99K	Hold	19,500	–	–	0.02%	105
2018 Q4	$37K	Buy	+19,500	New	+$55.8K	0.01%	93

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJ Wealth Strategies's CPRX Position: Q2 2023 in Review

AJ Wealth Strategies held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2023 at 15,241 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #282.

AJ Wealth Strategies first reported a position in CPRX in Q4 2018 and has held it in 19 quarters since. The position peaked at $283K in Q4 2022. 248 funds tracked by Wall St. Rank hold CPRX as of Q2 2023.

AJ Wealth Strategies held 15,241 shares of Catalyst Pharmaceutical worth $205K as of Q2 2023.
AJ Wealth Strategies left its Catalyst Pharmaceutical share count unchanged in Q2 2023.
Catalyst Pharmaceutical made up 0.01% of AJ Wealth Strategies's portfolio in Q2 2023, its #282 holding.
AJ Wealth Strategies first reported a position in Catalyst Pharmaceutical in Q4 2018 and has held it in 19 quarters since.
AJ Wealth Strategies's Catalyst Pharmaceutical position peaked at $283K in Q4 2022.
248 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2023.

Based on AJ Wealth Strategies's 13F filing for Q2 2023, filed 20 Jul 2023.